Diabetes Devices Market to Reach USD 64.8 Billion by 2033 at 7.7% CAGR; North America Leads with 41% Share - Key Players: Abbott Laboratories, Medtronic plc, Dexcom Inc., Insulet Corporation, Roche

The global diabetes devices market reached USD 33.4 billion in 2024 and is expected to reach USD 64.8 billion by 2033, growing at a CAGR of 7.7% during the forecast period 2025 to 2033. The market is witnessing steady growth driven by the rising prevalence of diabetes and increasing demand for advanced monitoring and management solutions.

Market growth is fueled by the growing incidence of lifestyle-related diseases, increasing obesity rates, and the aging population, all of which contribute to the rising burden of diabetes worldwide. The increasing adoption of continuous glucose monitoring (CGM) systems, insulin pumps, and smart insulin delivery devices is significantly enhancing patient care and driving market expansion. Additionally, growing awareness about early diagnosis and regular monitoring is further supporting demand for diabetes devices.

Diabetes devices play a critical role in effective disease management by enabling real-time monitoring, accurate insulin delivery, and improved glycemic control. Technological advancements such as integration with mobile applications, wearable devices, and data analytics platforms are enhancing user convenience and treatment outcomes. Furthermore, increasing healthcare expenditure, expanding access to advanced devices in emerging markets, and ongoing innovations in digital health are positioning the diabetes devices market as a key segment within the global medical devices industry.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/diabetes-devices-market?sai-v

Key Developments

✅ February 2026: Across North America, Europe, and Asia Pacific, rising prevalence of diabetes driven by obesity, aging populations, and sedentary lifestyles significantly accelerated demand for advanced glucose monitoring and insulin delivery devices. The need for continuous disease management continues to drive long-term adoption.

✅ January 2026: Globally, rapid advancements in continuous glucose monitoring (CGM), automated insulin delivery systems, and smart wearable devices improved real-time glucose tracking, enabled better glycemic control, and enhanced patient convenience through connected health ecosystems.

✅ December 2025: Leading companies such as Medtronic plc, Abbott Laboratories, Dexcom, Inc., Insulet Corporation, and F. Hoffmann-La Roche Ltd. focused on expanding CGM platforms, insulin pumps, and integrated diabetes management ecosystems, emphasizing automation and digital connectivity.

✅ November 2025: Increasing adoption of closed-loop insulin delivery systems (artificial pancreas), smart insulin pens, and mobile-connected devices improved treatment accuracy, reduced manual intervention, and enhanced patient adherence.

✅ October 2025: Companies intensified investments in non-invasive glucose monitoring technologies, AI-based predictive analytics, and remote patient monitoring systems to enable proactive and personalized diabetes care.

✅ September 2025: Across key regions including the United States, China, India, Germany, and Japan, expanding healthcare access, rising awareness, and increasing adoption of home-based diabetes management devices accelerated market growth.

The diabetes devices market is rapidly evolving toward fully connected, AI-driven diabetes ecosystems, where CGMs, insulin pumps, and mobile apps work together to deliver automated, real-time, and personalized disease management.

Key Players

F. Hoffmann-La Roche Ltd | Abbott Laboratories | Medtronic plc | Terumo Corporation | B. Braun SE | Insulet Corporation | Nipro Corporation | Johnson & Johnson Services, Inc. | Senseonics, Inc. | Tandem Diabetes Care, Inc. | Others

Purchase Corporate License | Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=diabetes-devices-market?sai-v

Market Drivers

Rising global prevalence of diabetes is significantly increasing demand for advanced glucose monitoring and insulin delivery devices.

Growing incidence of obesity, sedentary lifestyles, and unhealthy dietary habits is accelerating diabetes cases worldwide.

Increasing adoption of continuous glucose monitoring (CGM) systems is transforming real-time diabetes management and patient outcomes.

Rising demand for home-based care and self-monitoring devices is boosting market growth.

Advancements in insulin delivery technologies such as smart pens, insulin pumps, and automated systems are improving treatment efficiency.

Growing awareness of diabetes complications and preventive care is encouraging early monitoring and treatment.

Increasing healthcare expenditure and access to diabetes care in emerging economies are supporting market expansion.

Industry Developments

Rapid shift from traditional glucometers to continuous glucose monitoring (CGM) systems with real-time tracking and mobile integration.

Strong growth in automated insulin delivery systems (artificial pancreas) combining CGM and insulin pumps.

Advancements in wearable and minimally invasive glucose monitoring technologies improving patient convenience.

Expansion of smart insulin pens and connected devices enabling data-driven diabetes management.

Integration of AI, IoT, and mobile health platforms for predictive analytics and personalized care.

Increasing development of implantable CGM devices with longer sensor life and improved accuracy.

Rising investments and product launches by key players focusing on next-generation diabetes technologies.

Regional Insights

North America 41% share: "Leads the market due to high diabetes prevalence, advanced healthcare infrastructure, and strong adoption of CGM and insulin pump technologies."

Europe 27% share: "Growth driven by increasing awareness, favorable reimbursement policies, and adoption of advanced diabetes management devices."

Asia Pacific 24% share: "Fastest-growing region supported by large diabetic population, rising healthcare spending, and improving access to medical devices."

Latin America 5% share: "Emerging growth driven by increasing awareness and expanding healthcare infrastructure."

Middle East & Africa 3% share: "Gradual growth supported by rising diabetes incidence and improving healthcare systems."

Speak to our analyst and get customization in the report as per your requirements: https://www.datamintelligence.com/customize/diabetes-devices-market?sai-v

Key Segments

➥ By Product Type
Blood Glucose Monitoring Devices: Represent the dominant segment, driven by continuous need for regular glucose level tracking, increasing adoption of continuous glucose monitoring (CGM) systems, and rising diabetic population.

Insulin Delivery Devices: Represent a significant segment, supported by growing use of insulin pens, pumps, and automated delivery systems for effective diabetes management.

➥ By End-User
Homecare Settings: Represent the dominant segment, driven by increasing preference for self-monitoring, convenience, and availability of user-friendly diabetes devices.

Hospitals: Represent a significant segment, supporting diagnosis, treatment initiation, and management of critical diabetic conditions.

Specialty Clinics: Represent a notable segment, focusing on diabetes care, patient education, and routine monitoring.

Diagnostic Centers: Represent a growing segment, driven by demand for screening and diagnostic testing services.

Others: Include ambulatory care centers and research institutions contributing to diabetes management and innovation.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.